From Diagnosis to Discovery: How AI is Transforming Modern Medicine

The following is a guest article by Mansi Goel

For most of the last decade, AI in healthcare was mostly a back-office automation story – faster scan analysis, automated documentation, and detecting drug interactions. These were tools that executed tasks; they did not think through them.

The role of AI in healthcare is evolving. A new generation of AI systems can reason through complex medical problems, spot patterns across years of patient records, and connect findings across specialties. Instead of asking “is there pneumonia in this scan?” they can ask a much broader question: considering everything we know about this patient, their history, imaging, and lab results, what is most likely wrong and what are the next steps?

Such an approach – from prediction to reasoning – significantly changes the role of AI in healthcare. It moves AI from a tool that confirms what a clinician suspects to one that brings to fore what they might not have considered.

Is AI Close to Becoming a True Clinical Collaborator?

Closer than it was a few years ago. AI models like Microsoft’s Dragon Copilot have combined ambient listening with generative AI to automate consultation documentation and ease the physician’s workload.

The next generation of AI systems is expected to review a patient’s history before consultation, identify gaps in clinical investigation, and track changes across a patient’s journey. But controlled experiments are very different from real-world clinical practice. Modern AI cannot physically examine the patient, interpret body language, and family dynamics influencing treatment. Finally, the key element missing here is accountability. A clinician is accountable for their decision and, until suitable frameworks exist, the clinician should be making the decisions.

Perhaps the line of thought also needs to shift. Rather than asking whether AI can be a “collaborator”, the more pertinent question is whether it can be an “amplifier” that can help reduce the burden on physicians to analyze information and arrive at conclusions.

For AI to be considered in an amplifier role, improvement is required in four areas: reliability across diverse patient populations, explainability so doctors understand the reasoning behind a conclusion, reduced hallucination rates, and better data integration and regulatory parity. Fragmented data across health records, wearable devices, and imaging systems leaves AI reasoning with an incomplete picture.

Where Can AI Close the Diagnostic Gap?

If there is one area where AI can make an immediate and profound impact, it is helping diagnose rare and complex diseases. Approximately 300 million people across the globe suffer from a rare disease, and the average time to diagnose accurately can be between five and seven years.

What makes it frustrating is that such cases rarely go unsolved for lack of required knowledge. Usually, the clues are present in records, imaging, genomic data, and publications, but the issue lies in assembling and interpreting them quickly enough to change a patient’s care.

AI’s advantage is not superior reasoning. It is that it has seen more. A model trained on data from millions of cases can consider a rare diagnosis consistently regardless of how infrequently it appears in any single physician’s career.

Four near-future opportunities are clear: surfacing subtle contradictions in years of medical history; continuous reassessment as new data becomes available; real-time integration of current medical publications; and extending specialist-level diagnostic capability to places where no specialist is present.

For patients who have spent years lost in a diagnostic odyssey, the greatest value from AI may not even be the correct diagnosis. It might be the assistance in asking the right questions sooner.

What Must Always Stay in Human Hands?

As AI systems take on more of the burden of processing vast amounts of information, clinicians can have more time and mental bandwidth to exercise genuine medical judgment. With these advanced abilities, it becomes important to decide the boundaries between AI and human-controlled aspects of patient care.

There are situations where decisions are more about values than information. They involve tradeoffs: extending life versus preserving quality of life, or pursuing aggressive treatment versus avoiding harm. Two patients with identical diagnoses may make different treatment choices because they are different people with different lives. Decisions around aggressive treatment, palliative care, and end-of-life care require empathy and accountable moral judgment that no AI system can replicate.

Delivering a cancer diagnosis or sharing a terminal prognosis are among the most consequential conversations and demand human presence. AI can support such conversations but cannot replace them.

Human oversight should also be proportionate to risk. Automating prior authorization forms or drafting referral letters is relatively low risk, while adjusting medication dosing, triaging emergencies, or recommending treatment changes is much higher risk.

The future physician’s role will not be diminished by AI. The value of their presence lies in applying context and exercising judgment when information, ethics, and human choices are involved.

Looking Ahead

Diagnosis is one area likely to be impacted most by AI advancements. Rare disease diagnosis may be the first proving ground, with lessons extending to complex multisystem and treatment-resistant cases.

Over the longer term, preventive medicine may be transformed the most. As wearable sensors, home diagnostics, genomics, and longitudinal records become more connected, AI could identify disease risk before symptoms appear and transform patient care from reactive to predictive.

The larger opportunity is a continuous learning system where every diagnosis, treatment response, and research breakthrough improves future care. The future is not physicians versus AI. It is physicians who can see further because of AI, working inside a system that is more accurate, equitable, and proactive.

About Mansi Goel

Mansi Goel is a healthcare AI and clinical data science expert working at the intersection of machine learning, electronic health records, and real-world clinical model deployment. Her work focuses on developing and evaluating predictive models that use large-scale patient history to identify earlier disease signals and support clinical decision-making. She brings a practical perspective on the decisions that determine whether healthcare AI is useful, safe, and equitable, including how target variables are defined, cohorts are built, thresholds are selected, and performance is monitored across patient groups.

The following is a guest article by Mansi Goel

For most of the last decade, AI in healthcare was mostly a back-office automation story – faster scan analysis, automated documentation, and detecting drug interactions. These were tools that executed tasks; they did not think through them.

The role of AI in healthcare is evolving. A new generation of AI systems can reason through complex medical problems, spot patterns across years of patient records, and connect findings across specialties. Instead of asking “is there pneumonia in this scan?” they can ask a much broader question: considering everything we know about this patient, their history, imaging, and lab results, what is most likely wrong and what are the next steps?

Such an approach – from prediction to reasoning – significantly changes the role of AI in healthcare. It moves AI from a tool that confirms what a clinician suspects to one that brings to fore what they might not have considered.

Is AI Close to Becoming a True Clinical Collaborator?

Closer than it was a few years ago. AI models like Microsoft’s Dragon Copilot have combined ambient listening with generative AI to automate consultation documentation and ease the physician’s workload.

The next generation of AI systems is expected to review a patient’s history before consultation, identify gaps in clinical investigation, and track changes across a patient’s journey. But controlled experiments are very different from real-world clinical practice. Modern AI cannot physically examine the patient, interpret body language, and family dynamics influencing treatment. Finally, the key element missing here is accountability. A clinician is accountable for their decision and, until suitable frameworks exist, the clinician should be making the decisions.

Perhaps the line of thought also needs to shift. Rather than asking whether AI can be a “collaborator”, the more pertinent question is whether it can be an “amplifier” that can help reduce the burden on physicians to analyze information and arrive at conclusions.

For AI to be considered in an amplifier role, improvement is required in four areas: reliability across diverse patient populations, explainability so doctors understand the reasoning behind a conclusion, reduced hallucination rates, and better data integration and regulatory parity. Fragmented data across health records, wearable devices, and imaging systems leaves AI reasoning with an incomplete picture.

Where Can AI Close the Diagnostic Gap?

If there is one area where AI can make an immediate and profound impact, it is helping diagnose rare and complex diseases. Approximately 300 million people across the globe suffer from a rare disease, and the average time to diagnose accurately can be between five and seven years.

What makes it frustrating is that such cases rarely go unsolved for lack of required knowledge. Usually, the clues are present in records, imaging, genomic data, and publications, but the issue lies in assembling and interpreting them quickly enough to change a patient’s care.

AI’s advantage is not superior reasoning. It is that it has seen more. A model trained on data from millions of cases can consider a rare diagnosis consistently regardless of how infrequently it appears in any single physician’s career.

Four near-future opportunities are clear: surfacing subtle contradictions in years of medical history; continuous reassessment as new data becomes available; real-time integration of current medical publications; and extending specialist-level diagnostic capability to places where no specialist is present.

For patients who have spent years lost in a diagnostic odyssey, the greatest value from AI may not even be the correct diagnosis. It might be the assistance in asking the right questions sooner.

What Must Always Stay in Human Hands?

As AI systems take on more of the burden of processing vast amounts of information, clinicians can have more time and mental bandwidth to exercise genuine medical judgment. With these advanced abilities, it becomes important to decide the boundaries between AI and human-controlled aspects of patient care.

There are situations where decisions are more about values than information. They involve tradeoffs: extending life versus preserving quality of life, or pursuing aggressive treatment versus avoiding harm. Two patients with identical diagnoses may make different treatment choices because they are different people with different lives. Decisions around aggressive treatment, palliative care, and end-of-life care require empathy and accountable moral judgment that no AI system can replicate.

Delivering a cancer diagnosis or sharing a terminal prognosis are among the most consequential conversations and demand human presence. AI can support such conversations but cannot replace them.

Human oversight should also be proportionate to risk. Automating prior authorization forms or drafting referral letters is relatively low risk, while adjusting medication dosing, triaging emergencies, or recommending treatment changes is much higher risk.

The future physician’s role will not be diminished by AI. The value of their presence lies in applying context and exercising judgment when information, ethics, and human choices are involved.

Looking Ahead

Diagnosis is one area likely to be impacted most by AI advancements. Rare disease diagnosis may be the first proving ground, with lessons extending to complex multisystem and treatment-resistant cases.

Over the longer term, preventive medicine may be transformed the most. As wearable sensors, home diagnostics, genomics, and longitudinal records become more connected, AI could identify disease risk before symptoms appear and transform patient care from reactive to predictive.

The larger opportunity is a continuous learning system where every diagnosis, treatment response, and research breakthrough improves future care. The future is not physicians versus AI. It is physicians who can see further because of AI, working inside a system that is more accurate, equitable, and proactive.

About Mansi Goel

Mansi Goel is a healthcare AI and clinical data science expert working at the intersection of machine learning, electronic health records, and real-world clinical model deployment. Her work focuses on developing and evaluating predictive models that use large-scale patient history to identify earlier disease signals and support clinical decision-making. She brings a practical perspective on the decisions that determine whether healthcare AI is useful, safe, and equitable, including how target variables are defined, cohorts are built, thresholds are selected, and performance is monitored across patient groups.